Dr. Rakesh P. Mehta, MD

Dr. Mehta practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Mehta's NPI, 1174589600, was assigned on April 24, 2006. Dr. Mehta graduated from Pennsylvania State University College of Medicine in 1993. Dr. Mehta holds Indiana license 01056445A.

Dr. Mehta's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Mehta's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Mehta is also affiliated with Sidney & Lois Eskenazi Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Mehta to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Mehta is board certified in hematology by the American Board of Internal Medicine. Dr. Mehta is licensed in Indiana.

CMS data shows 272 Medicare services from Dr. Mehta across 4 procedure codes in 2024, for 189 Medicare patients. Medicare paid $18,152 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 189 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 93 patients. 72% of them have high blood pressure, and 62% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 53, with 65% women.

In 2024, Dr. Mehta wrote 1,802 Medicare Part D claims for 175 patients. 75% of them were for generic drugs. CMS names the drug for 1,514 of them, across 32 drugs with 11 or more claims each, at $547,754 in total drug cost. In 2023, CMS named 1,560 claims across 33 drugs.

Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 10 papers to Dr. Mehta, published from 2016 to 2024. 2016 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Attitude of Health Personnel and Empathy. Dr. Mehta has published most often in Am J Hosp Palliat Care. Dr. Mehta's most frequent co-authors are Larry D. Cripe, MD, Caroline Jane Diorio, MD and Michael J. Econs, MD.

Dmand AI links Dr. Mehta to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hypophosphatemic Rickets, Autosomal Dominant, Postthrombotic Syndrome and Hypophosphatemia.

CMS Open Payments shows 1 general payment to Dr. Mehta from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $13.

Dr. Mehta graduated from Pennsylvania State University College of Medicine in 1993.